The Hemodialysis and Peritoneal Dialysis Market is moving through a major transformation as the global burden of kidney disease continues to increase and healthcare systems look for more flexible ways to deliver long-term renal care. The global Hemodialysis and Peritoneal Dialysis Market was valued at USD 119.5 billion in 2025 and is projected to reach USD 250.4 billion...

 Certificates Market size was valued at US$ 5.22 Bn. in 2022 and the total revenue is expected to grow at 5.5 % through 2023 to 2029, reaching nearly US$ 7.59 Bn. Certificates Market Overviews In order to verify that a product is safe to use, certificate organizations create certificates that are authorized for usage. The organization that issues certificates verifies and tests items based...

Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to boost the growth of the market. Moreover, presence of well-established key players focusing on developing and commercializing technologically advanced and initiatives undertaken by government to increase the awareness...

Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about CRRT therapy along with the increase in the launch of advanced CRRT system area anticipated to fuel the CRRT market growth during the forecast period.    According to a new market research...

[181 Pages Report] The global continuous renal replacement therapy size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent...

[181 Pages Report] The global continuous renal replacement therapy market size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over...